<DOC>
	<DOCNO>NCT02213172</DOCNO>
	<brief_summary>The purpose study determine two different probiotic strain , Lactobacillus paracasei HA-196 Bifidobacterium longum R0175 , effective help subject manage symptom IBS</brief_summary>
	<brief_title>Evaluation Efficacy Two Probiotic Strains Irritable Bowel Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Sulfalene</mesh_term>
	<criteria>Male female age 18 year old . IBS diagnosis accord Rome III criterion referral study clinician . That , recurrent abdominal pain discomfort ( i.e. , uncomfortable sensation pain ) least 2 days/month last 3 month ( response question 1 IBS Rome III module questionnaire &gt; 2 ) associate 2 following : Improvement defecation ( response question 4 IBS Rome III module questionnaire &gt; 0 ) ; Onset associate change stool frequency ( response question 5 6 IBS Rome III module questionnaire &gt; 0 ) ; Onset associate change stool form ( appearance ) . ( response question 7 8 IBS Rome III module questionnaire &gt; 0 ) . For woman , abdominal pain discomfort experience day menstrual bleeding ( response question 2 IBS Rome III module questionnaire = 0 2 ) Criterion must fulfil last 3 month symptom onset least 6 month prior screen ( response question 3 IBS Rome III module questionnaire = 1 ) . A copy IBS module provide Appendix A : IBS Rome III Module Questionnaire Participants general population IBS symptom , without previous diagnosis , assess Principle Investigator include study differential diagnosis confirms IBS . The Principle Investigator confirm diagnosis IBS potential participant previous diagnosis IBS . Subjects experience pain/discomfort frequency least 2 day week runin period . At visit 2 , subject ask `` In last 2 week , often week discomfort pain anywhere abdomen ? `` . The answer must least 2 . Subjects diagnose IBS depression may include Absence black color ( melena ) blood stool . Willingness complete questionnaire , record , diary associate study complete clinic visit . Willingness discontinue consumption probiotic ( e.g . yogurt , live , active culture supplement ) . Able provide inform consent . Subjects history suicidal ideation , current suicidal ideation Previous history gastrointestinal surgery ( except appendectomy , cholecystectomy , hernia repair , hemorrhoidectomy ) . Other gastrointestinal disease ( except hemorrhoid uncomplicated diverticulum ) , assess ultrasonography , colonoscopy , rectoscopy , history Clostridium difficileassociated diarrhea . A family history ( immediate family i.e . sibling parent ) colorectal cancer , inflammatory bowel disease and/or celiac spruce . Coexisting organic gastrointestinal disease . Presence rectal bleeding , recent weight loss ( great 5 kg past month ) iron deficiency anemia . History , current diagnosis , liver disease , kidney disease , pulmonary disease , cardiovascular disease , pancreatic disease , cancer . Presence immunecompromised condition AIDS , lymphoma undergoing longterm corticosteroid treatment Presence history neurological disorder , significant psychiatric illness . History , current diagnosis , pelvic floor dyssynergia . Positive drug alcohol screen recent history drug alcohol abuse ( within 3 year screen ) . Milk soy allergy . Use another investigational product within 3 month screen visit . The screened participant could eligible participate washout period . Positive pregnancy test woman childbearing potential . Pregnant breastfeeding plan become pregnant . Women childbearing potential use effective contraception . Acceptable method birth control include : Hormonal contraceptive include oral contraceptive , hormone birth control patch ( Ortho Evra ) , vaginal contraceptive ring ( NuvaRing ) , injectable contraceptive ( DepoProvera , Lunelle ) , hormone implant ( Norplant System ) Intrauterine device Vasectomy partner ( show successful per appropriate followup ) Double barrier method ( use physical barrier partner ) Use antibiotic drug ( e.g. , neomycin , rifaximin ) within 1 month screening . The screened participant could eligible participate 1 month washout period . Use PPI H2R antagonist within 1 month screening . The screened participant could eligible participate 1 month washout period . Daily use nonsteroidal antiinflammatory drug , cortisone , antiinflammatory drug 1 month prior screen . The screened participant could eligible participate 1 month washout period . Current use , use within past 1 month , narcotic medication IBS symptom management ( e.g . alosetron , tegaserod , lubiprostone , antispasmodic , antidiarrheal , laxative , antipsychotic , tricyclic antidepressant , selective serotonin reuptake inhibitor ( SSRIs ) ) . Subjects take stable dose antidepressant least 30 day plan change dosage trial eligible inclusion study . Regular use antidiarrhea medication laxatives . Occasional use permit prior screening ( â‰¤ month ) ; current use &gt; per month one month wash period need prior screening .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>IBS</keyword>
	<keyword>Probiotic</keyword>
	<keyword>Constipation</keyword>
	<keyword>Bifidobacterium longum</keyword>
	<keyword>Lactobacillus paracasei</keyword>
	<keyword>Lallemand Health Solutions</keyword>
</DOC>